SPONSORED

 

A Major Dr-ug Discovery Could Be Game-Changing for the Potential $245 Billion Weight Management Market(1)

NeonMind Biosciences May Have Unearthed “Nature’s Own Appetite Suppressant” for Millions Considered Overweight or Obese(2)

Canada CSE: (NEON) United States OTC: (NMDBF)

September 16, 2021:

NeonMind Appoints Ket-a-mine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board

The obesity issue in the U.S is out of control.

Consider some of these stats:(3)

  • Nearly one out of every three adults could be obese, according to a Harvard study.
  • About 18.5% of children, some as young as two years old, are considered obese.
  • It costs U.S. taxpayers nearly $150 billion per year to fight obesity issues.

But wait, it gets worse.

Right now, obesity may account for approximately 37% of the global burden of disease.(4)

By 2030, about 20% of the global population could also be obese, according to the National Centers for Biotechnology Information. In addition, obesity is linked to more than 60 chronic diseases, including  type 2 diabetes, heart disease, stroke, and cancer.(3)

In short, the world may be eating itself to an early grave.

However, according to NeonMind Biosciences Canada CSE: (NEON) United States OTC: (NMDBF), help could be on the way in the form of psi-lo-cybin, which could potentially revolutionize the weight loss market, and help millions shed unwanted weight.

After all, psi-lo-cybin activates serotonin receptors, or “nature’s own appetite suppressant,” as noted by Psychology Today. “This powerful brain chemical curbs cravings and shuts off appetite. It makes you feel satisfied even if your stomach is not full. The result is eating less and losing weight.”(2)

The Top Reasons to Consider NeonMind Biosciences Canada CSE: (NEON) United States OTC: (NMDBF)

  1. Psi-lo-cybin could potentially revolutionize treatment in the potential $245.5 billion weight loss market, and may activate serotonin receptors that can curb cravings, shut off appetite, reduce eating, and cause weight loss.(1)
  2. Health Canada approved NeonMind’s preclinical psi-lo-cybin trials as a potential treatment for weight loss and food addiction.(5)
  3. NeonMind commenced its pre-clinical trials in 2020 and plans to have enough data for its scheduled Phase 2 human clinical trials in early 2021. To date, a completed pre-clinical study demonstrated weight sparing clinical signal for low and high-dose psi-lo-cybin regime.(1)
  4. If successful, NeonMind could have potential access to approximately 1.9 billion people who are currently overweight or obese.(1)
  5. NeonMind is uniquely positioned in the psych-e-delics market.  It’s one of two companies currently working on developing psi-lo-cybin into a prescription dr-ug for weight management.(1)
  6. Its patent portfolio provides protection for therapeutic use of psi-lo-cybin and derivatives for weight management.(1)
  7. NeonMind completed a supply agreement with Psygen Labs for psi-lo-cybin for clinical studies.(6)
  8. NeonMind also has a solid management team with significant experience in dr-ug development and commercialization, and has extensive U.S. and international patents pending for a spectrum of weight management conditions.
  9. NeonMInd has multiple anticipated milestones for 2021, including the engagement of expert integrated dr-ug development organization, preclinical study #2: data expected 2Q21, Phase 2 study design and first patient enrolled 4Q21, dietary supplement launch in US 2Q21, natural health products launch in Canada 3Q21, the expansion of current IP portfolio, and a pre-IND meeting with FDA 4Q21.(1)

Just Who is NeonMind Biosciences Canada CSE: (NEON) United States OTC: (NMDBF)?

At the moment, NeonMind Biosciences, has two dr-ug development candidates exploring psi-lo-cybin as an innovative treatment approach to treat obesity and support weight loss.

NeonMind’s first dr-ug candidate employs psi-lo-cybin as an agonist to the serotonin receptor 5-HT2A, which is involved in the hallucinogenic effect of psych-e-delics.  The second dr-ug candidate employs psi-lo-cybin as an agonist to the serotonin 5-HT2C receptor, which controls appetite.

The company is also working with Dr. C. Laird Birmingham, a Specialist in Internal Medicine, an Epidemiologist and Biostatistician, and a Professor of Psychiatry at the University of British Columbia.  He’ll consult with the company to develop protocols for its Phase 2 Clinical Trial administering psi-lo-cybin to treat obese patients.(7)

NeonMind also just engaged Certara, the global leader in model-informed dr-ug development to provide strategic integrated dr-ug development support for the investigation of NeonMind’s psi-lo-cybin based dr-ug candidates for the treatment of obesity.(8)

NeonMind Biosciences Canada CSE: (NEON) United States OTC: (NMDBF)– Already Seeing Significant Success

For one, the company’s proprietary animal data supports psi-lo-cybin efficacy in reducing weight gain.

Two, weight reduction has been seen in a short period of time.(1)

Three, the novel data strengthens patent applications.

From here, the company has key anticipated milestones for the year.(1)

  • Engagement of expert integrated dr-ug development organization
  • Preclinical study #2: data expected 2Q21
  • Phase 2 study design and first patient enrolled 4Q21
  • Dietary Supplement launch in US 2Q21
  • Natural Health Products launch in Canada 3Q21
  • Expand current IP portfolio
  • Pre-IND meeting with FDA 4Q21

Plus, as NeonMind President and CEO Rob Tessarolo notes: 

“It is a very exciting time to be in the psych-e-delics industry, which is undergoing rapid expansion. There is a continuous flow of new companies entering the market and each is replete with important research ideas and vying for the conditions necessary to drive growth.  The growing interest in studying psych-e-delic substances coupled with a fresh look from regulatory agencies means some of these substances have the potential to make it to market and help those patients who need innovative new approaches in care. We have established a distinctive focus on developing innovative treatment modalities for people dealing with obesity.”(9)

“Psych-e-delic therapy has the potential to institute long term positive behaviors that may impact food intake and other lifestyle changes which affect weight management, and psi-lo-cybin in low doses may help control appetite and satiety. This important element sets us apart from numerous other psych-e-delic companies working to advance research ideas in psych-e-delic.”(9)

Is There a Good Deal of Support for Psych-e-delic Treatments?

Look at the evidence. It doesn’t lie.

  • The US FDA appears to be supportive of psi-lo-cybin research. In 2019, for example, the agency recognized psi-lo-cybin as a potentially “breakthrough therapy” for depression.(10)
  • As noted by NPR, a study from JAMA Psychiatry recently found that psi-lo-cybin “worked better than the usual antidepressant medications.”(11)
  • Johns Hopkins Medicine launched the Center for Psych-e-delic and Consciousness Research to study how compounds like LS and psi-lo-cybin could potentially treat mental health problems such as anorexia, addiction and depression.(12)
  • A study in the journal, Nature said that “Psi-lo-cybin for treatment-resistant depression: fMRI-measured brain mechanisms” – showed that around 47% of patients with treatment-resistant-depression showed positive responses approximately five weeks after psi-lo-cybin treatments.”(13)
  • State and local governments are also beginning to accept its usage as well. In fact, Oregon just became the first state to officially decriminalize the possession of psych-e-delics, joining Denver, Oakland, and Santa Cruz’s decisions on psi-lo-cybin.(14)

However, This is Just a Fraction of the NeonMind Growth Story 

NeonMind is also commercializing mush-room-infused food products- including products infused with Lion’s Mane, Turkey Tail, Reishi and Cordyceps.

Additionally, the company launched a coffee eCommerce platform in November 2020 with infused coffees.

This platform has immense potential, because people are reportedly craving infused coffees and teas for an “added superfood go-to morning beverage,” according to Yahoo Life.

“Mush-rooms have long been used in Chinese medicine and newer research shows they are the highest dietary source of the antioxidants ergothioneine and glutathione, which help protect the body against the type of damage that can eventually contribute to age-related diseases like cancer, heart disease, Parkinson’s and Alzheimer’s,” says Beth Warren, RDN, author of Secrets of a Kosher Girl. “Mush-room coffees and teas can give anyone a boost, but they may be especially beneficial for those who are dealing with chronic diseases and inflammation.”(15)

Some of the products being offered by NeonMind include:(16)

INSTANT COFFEES

  • Rest Blend — A well-balanced coffee infused with Lion’s Mane and Reishi mush-rooms, as well as Ashwagandha and Turmeric.
  • Energize Blend — Robust coffee infused with Turkey Tail and Cordycep mush-rooms, blended with Holy Basil and Moringa.

BREWED COFFEES

  • Focus Blend – Dark Roast — A well-balanced coffee infused with Lion’s Mane and Reishi mush-rooms, combined with Gotu Kola and Brahmi.
  • Protect Blend – Medium Roast — A robust coffee infused with Turkey Tail and Cordycep mush-rooms, blended with the Moringa and Amla Berry.

NeonMind Biosciences Canada CSE: (NEON) United States OTC: (NMDBF): Strong Leadership, Strong Results  

Successful companies tend to possess common traits, and one of those traits is a strong management team. NeonMind Biosciences certainly has that covered well.

ROBERT TESSAROLO
PRESIDENT & CHIEF EXECUTIVE OFFICER

  • Over 25 years of experience in the pharmaceutical industry
  • Former President, CEO and Director of Mind Medicine Inc.

TREVOR MILLAR
CHIEF PSYCH-E-DELIC OFFICER

  • Social-entrepreneur advancing the psych-e-delic movement since 2013
    Board Chairman Multidisciplinary Association of Psych-e-delic Studies (MAPS) Canada
    Co-Founder and Board Member Canadian Psych-e-delic Association.
  • Founder of Liberty Root Therapy Inc.; featured in the award-winning psych-e-delic documentary ‘DOSED’

RICK HUANG
CFO

  • CFO of Better Plant Sciences Inc. (CSE: PLNT)
    Serves as Chair of the Audit Committee for Datable
  • Technology Corp. (TSXV: TTM)
    Former CFO of Hanwei Energy Services Corp.
  • Former Chair of Governance and member of Audit
  • Committees at Poydras Gaming Finance Corp.
  • Former President & CEO of Cipher Pharmaceuticals Inc.
  • Former VP, General Manager Celgene US Inflammation & Immunology and former President Watson Pharmaceuticals Canada

PENNY WHITE
EXECUTIVE CHAIRMAN, DIRECTOR, FOUNDER

  • Serial entrepreneur with over two decades of experience building companies.
  • Recognized in PROFIT Magazine’s W100
  • Co-founder, President and CEO of Better Plant Sciences Inc.
  • Former Director Merus Labs Inc.

JEFF B. SMITH
INDEPENDENT DIRECTOR

  • Over 30 years of general management experience
  • Previously the Global Chief Transformation Officer at Johnson & Johnson Consumer Companies
  • Co-Founder and CEO of Paragon Vitamins and
    Co-Founder & Partner at Ignite Ventures Studios

KARI RICHARDSON
INDEPENDENT DIRECTOR

  • Over 15 years practicing as a securities lawyer
  • Partner of Owen Bird Law; practice focused on mergers
  • and acquisitions, corporate finance and securities.
    Member of the Law Society of New Brunswick since 1997 and a member of the Law Society of British Columbia since 2005.

WILLIAM PANENKA
CHAIR, SCIENTIFIC ADVISORY BOARD

  • Dually boarded Neurologist and Psychiatrist and Canadian Institute of Health Research funded academic faculty member at the University of British Columbia.
  • Founder and Director, Translational Life Sciences Inc.

LAIRD BIRMINGHAM
MEMBER, ADVISORY BOARD

  • World renowned eating disorder specialist for over 35 years, who has pioneered several new internationally recognized treatments for eating disorders
  • Professor at the University of British Columbia, Faculty of Medicine Department of Psychiatry

ALASDAIR BARR
PRINCIPAL INVESTIGATOR

  • PhD in Neuropharmacology, post-doctoral training at Scripps Institute and dr-ug discovery with Novartis.
  • Tenured Faculty member at the Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, UBC
  • Approved by Health Canada to possess psi-lo-cybin for NeonMind Preclinical trial

The Top Reasons to Consider NeonMind Biosciences Canada CSE: (NEON) United States OTC: (NMDBF)

  1. Psi-lo-cybin could potentially revolutionize treatment in the potential $245.5 billion weight loss market, and may activate serotonin receptors that can curb cravings, shut off appetite, reduce eating, and cause weight loss.(1)
  2. Health Canada approved NeonMind’s preclinical psi-lo-cybin trials as a potential treatment for weight loss and food addiction.(5)
  3. NeonMind commenced its pre-clinical trials in 2020 and plans to have enough data for its scheduled Phase 2 human clinical trials in early 2021. To date, a completed pre-clinical study demonstrated weight sparing clinical signal for low and high-dose psi-lo-cybin regime.(1)
  4. If successful, NeonMind could have potential access to approximately 1.9 billion people who are currently overweight or obese.(1)
  5. NeonMind is uniquely positioned in the psych-e-delics market. It’s one of two companies currently working on developing psi-lo-cybin into a prescription dr-ug for weight management.(1)
  6. Its patent portfolio provides protection for therapeutic use of psi-lo-cybin and derivatives for weight management.(1)
  7. NeonMind completed a supply agreement with Psygen Labs for psi-lo-cybin for clinical studies.(6)
  8. NeonMind also has a solid management team with significant experience in dr-ug development and commercialization, and has extensive U.S. and international patents pending for a spectrum of weight management conditions.
  9. NeonMInd has multiple anticipated milestones for 2021, including the engagement of expert integrated dr-ug development organization, preclinical study #2: data expected 2Q21, Phase 2 study design and first patient enrolled 4Q21, dietary supplement launch in US 2Q21, natural health products launch in Canada 3Q21, the expansion of current IP portfolio, and a pre-IND meeting with FDA 4Q21.(1)
Source 1: https://neonmindbiosciences.com/wp-content/uploads/investors/NeonMind_Investor.pdf
Source 2: https://www.psychologytoday.com/us/blog/the-antidepressant-diet/201008/serotonin-what-it-is-and-why-its-important-weight-loss
Source 3: https://www.singlecare.com/blog/news/obesity-statistics/
Source 4: https://neonmindbiosciences.com
Source 5: https://bit.ly/3fhbRYJ
Source 6: https://money.yahoo.com/better-plant-sciences-subsidiary-neonmind-070000231.html
Source 7: https://bit.ly/3rr9ANh
Source 8: https://currently.att.yahoo.com/att/neonmind-engages-certara-advance-synthetic-110000514.html
Source 9: https://bit.ly/3ddFDLi
Source 10: https://bit.ly/3w3YsZV
Source 11: https://n.pr/31kO5TJ
Source 12: https://bit.ly/3fiSAX8
Source 13: https://www.nature.com/articles/s41598-017-13282-7
Source 14: https://bit.ly/31o8KWY
Source 15: https://coffeetalk.com/daily-dose/for-roasters-retailers/10-2020/70095/
Source 16: https://neonmind.com/

Legal Disclaimer


This website / media webpage is owned, operated and edited by TD Media LLC. Any wording found on this website / media webpage or disclaimer referencing to “I” or “we” or “our” or “TD Media” refers to TD Media LLC. This website / media webpage is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies. By reading our website / media webpage you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage.We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website / media webpage are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our website / media webpage may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. TD Media business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our Websites, Email, SMS, Push Notifications, Influencers, Social Media Postings, Ticker Tags, Press Releases, Online Interviews, Podcasts, Videos, Audio Ads, Banner Ads, Native Ads, Responsive Ads. This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, TD Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.

BLOGGER COMPENSATION

Pursuant to an agreement between TD Media LLC and Blogger, TD Media LLC has hired Blogger for a period beginning on 06/10/2021 and ending on 06/10/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Blogger five hundred dollars USD.

INFLUENCER COMPENSATION

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 01/22/2021 and ending on 01/22/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer eight hundred dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 01/26/2021 and ending on 01/26/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer one thousand five hundred forty five dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 01/26/2021 and ending on 01/26/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer six hundred dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 01/27/2021 and ending on 01/27/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer seven hundred fifty dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 04/01/2021 and ending on 04/01/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer one thousand dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 04/01/2021 and ending on 04/01/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer four hundred dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 04/07/2021 and ending on 04/07/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer one hundred fifty dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 04/30/2021 and ending on 04/30/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer five hundred dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 05/13/2021 and ending on 05/13/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer one thousand dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 05/13/2021 and ending on 05/13/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer eight hundred fifty dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 05/14/2021 and ending on 05/14/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer one thousand dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 06/10/2021 and ending on 06/10/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer eight hundred fifty dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 06/10/2021 and ending on 06/10/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer one hundred twenty dollars USD.

Pursuant to an agreement between TD Media LLC and Influencer, TD Media LLC has hired Influencer for a period beginning on 06/10/2021 and ending on 06/10/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have paid this Influencer one hundred dollars USD.

COMPENSATION

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 12/31/2020 and ending on 01/08/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid twenty thousand dollars USD via bank wire transfer.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 01/09/2021 and ending on 01/29/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional eighty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid one hundred thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 01/25/2021 and ending on 01/29/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional fifty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid one hundred fifty thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 02/01/2021 and ending on 02/05/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional fifty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid two hundred thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 02/08/2021 and ending on 02/12/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid two hundred thirty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 02/16/2021 and ending on 02/22/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid two hundred sixty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 02/23/2021 and ending on 02/26/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid two hundred ninety five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 03/01/2021 and ending on 03/05/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional fifty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid three hundred forty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 03/08/2021 and ending on 03/12/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid three hundred seventy five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 03/15/2021 and ending on 03/19/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid four hundred ten thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 03/22/2021 and ending on 03/26/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid four hundred forty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 03/29/2021 and ending on 04/05/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid four hundred eighty thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 04/06/2021 and ending on 04/12/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid five hundred fifteen thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 04/13/2021 and ending on 04/16/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid five hundred fifty thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 04/17/2021 and ending on 04/26/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional twenty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid five hundred seventy thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 04/27/2021 and ending on 04/30/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional twenty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid five hundred ninety thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 05/03/2021 and ending on 05/07/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid six hundred twenty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 05/10/2021 and ending on 05/14/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid six hundred fifty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 05/17/2021 and ending on 05/21/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid six hundred eighty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 05/24/2021 and ending on 05/28/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid seven hundred fifteen thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 05/31/2021 and ending on 06/04/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional ten thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid seven hundred twenty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 06/07/2021 and ending on 06/18/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional thirty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid seven hundred fifty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 06/21/2021 and ending on 06/25/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We expect to be paid an additional five thousand dollars USD To date we have not been paid. We own zero shares of (NMDBF:US) (NEON:CA).

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 06/28/2021 and ending on 07/02/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We expect to be paid an additional five thousand dollars USD To date we have not been paid. We own zero shares of (NMDBF:US) (NEON:CA).

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 07/05/2021 and ending on 07/16/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional ten thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid seven hundred seventy five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 07/19/2021 and ending on 08/01/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional ten thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid seven hundred eighty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 08/02/2021 and ending on 08/13/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional ten thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid seven hundred ninety five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 08/16/2021 and ending on 08/25/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional ten thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid eight hundred five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 08/26/2021 and ending on 08/27/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid eight hundred ten thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 08/30/2021 and ending on 09/10/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid eight hundred fifteen thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 09/13/2021 and ending on 09/17/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid eight hundred twenty thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 09/18/2021 and ending on 09/19/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional five thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid eight hundred twenty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.

Pursuant to an agreement between TD Media LLC and NeonMind Biosciences, TD Media LLC has been hired for a period beginning on 09/20/2021 and ending on 10/01/2021 to publicly disseminate information about (NMDBF:US) (NEON:CA) via digital communications. We have been paid an additional forty thousand dollars USD via bank wire transfer. We own zero shares of (NMDBF:US) (NEON:CA). To date we have been paid eight hundred sixty five thousand dollars USD via bank wire transfer. To disseminate information about (NMDBF:US) (NEON:CA) via digital communications.